LINK WILLIAM J PHD — SEC insider filings

SEC reporting owner CIK 1228684. 55 insider filings on record with FilingPulse; latest filed 2026-09-17.

Transaction summary — filings shown

Covers the 50 most recent of 55 filings on record, filed 2021-05-14 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Oyster Point Pharma, Inc. (OYST)Director5—4 legs · 550,000 sh · $8,160,7368
Tarsus Pharmaceuticals, Inc. (TARS)Director21—16 legs · 122,562 sh · $6,939,30937
RxSight, Inc. (RXST)Director171 leg · 31,250 sh · $500,0002 legs · 28,250 sh · $1,403,12024
LENSAR, Inc. (LNSR)Director6——8
GLAUKOS Corp (GKOS)Director1——1

Insider filings — LINK WILLIAM J PHD

FiledFormIssuerReported transactionsSource
2026-09-174Tarsus Pharmaceuticals, Inc. (TARS)Option exercise (M): 201 · Sale (S): 11,675 @ $78.33 · Sale (S): 759 @ $79 · Sale (S): 66 @ $80.01 · Option exercise (M): 201 (derivative) @ $0EDGAR
2026-06-294Tarsus Pharmaceuticals, Inc. (TARS)Grant/award (A): 3,837 (derivative) @ $0 · Grant/award (A): 2,417 (derivative) @ $0 · Grant/award (A): 806 (derivative) @ $0EDGAR
2026-06-184RxSight, Inc. (RXST)Grant/award (A): 37,037EDGAR
2026-06-174Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 10,572 @ $61.97 · Sale (S): 1,928 @ $62.94EDGAR
2026-06-164Tarsus Pharmaceuticals, Inc. (TARS)Option exercise (M): 2,954 · Option exercise (M): 2,954 (derivative) @ $0EDGAR
2026-06-054LENSAR, Inc. (LNSR)Grant/award (A): 17,421 @ $0EDGAR
2026-03-184Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 3,629 @ $68.09 · Sale (S): 8,378 @ $69.03 · Sale (S): 493 @ $69.75EDGAR
2025-12-174Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 5,046 @ $80.80 · Sale (S): 6,306 @ $81.75 · Sale (S): 1,148 @ $82.39 · Sale (S): 5,680 @ $80.71 · Sale (S): 4,766 @ $81.50EDGAR
2025-09-184Tarsus Pharmaceuticals, Inc. (TARS)Gift (G): 2,000 @ $0EDGAR
2025-09-104Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 27,116 @ $57EDGAR
2025-06-164Tarsus Pharmaceuticals, Inc. (TARS)Option exercise (M): 3,350 · Grant/award (A): 4,540 (derivative) @ $0 · Grant/award (A): 2,954 (derivative) @ $0 · Option exercise (M): 3,350 (derivative) @ $0EDGAR
2025-06-044RxSight, Inc. (RXST)Grant/award (A): 10,752EDGAR
2025-05-284LENSAR, Inc. (LNSR)Grant/award (A): 7,374 @ $0EDGAR
2024-08-144Tarsus Pharmaceuticals, Inc. (TARS)Other (J): 74,892 @ $0 · Other (J): 10,446 @ $0 · Other (J): 27,116 @ $0 · Sale (S): 29,979 @ $26.01 · Sale (S): 5,021 @ $26.53EDGAR
2024-06-254Tarsus Pharmaceuticals, Inc. (TARS)Option exercise (M): 3,350 · Option exercise (M): 3,350 (derivative) @ $0EDGAR
2024-06-144Tarsus Pharmaceuticals, Inc. (TARS)Grant/award (A): 5,000 (derivative) @ $0 · Grant/award (A): 3,350 (derivative) @ $0EDGAR
2024-06-104RxSight, Inc. (RXST)Grant/award (A): 2,554EDGAR
2024-05-094LENSAR, Inc. (LNSR)Grant/award (A): 22,000 @ $0EDGAR
2024-02-024RxSight, Inc. (RXST)Sale (S): 20,598 @ $49.54 · Sale (S): 7,652 @ $50.01 · Gift (G): 3,000 @ $0EDGAR
2023-08-184RxSight, Inc. (RXST)Other (J): 694,124 @ $0 · Other (J): 2,610 @ $0 · Other (J): 21,248 @ $0EDGAR
2023-06-264Tarsus Pharmaceuticals, Inc. (TARS)Grant/award (A): 5,000 (derivative) @ $0 · Grant/award (A): 3,350 (derivative) @ $0EDGAR
2023-06-214Tarsus Pharmaceuticals, Inc. (TARS)Option exercise (M): 2,000 · Option exercise (M): 2,000 (derivative) @ $0EDGAR
2023-06-054RxSight, Inc. (RXST)Grant/award (A): 5,731 @ $0EDGAR
2023-05-304LENSAR, Inc. (LNSR)Grant/award (A): 9,288 @ $0 · Grant/award (A): 33,175 (derivative) @ $0EDGAR
2023-05-154Tarsus Pharmaceuticals, Inc. (TARS)Other (J): 215,576 @ $0 · Other (J): 41,219 @ $0EDGAR
2023-05-124RxSight, Inc. (RXST)Other (J): 258,390 @ $0 · Other (J): 98,715 @ $0EDGAR
2023-03-174Tarsus Pharmaceuticals, Inc. (TARS)Other (J): 215,575 @ $0 · Other (J): 52,194 @ $0EDGAR
2022-11-144RxSight, Inc. (RXST)Other (J): 316,694 @ $0 · Other (J): 107,236 @ $0EDGAR
2022-11-144Tarsus Pharmaceuticals, Inc. (TARS)Other (J): 215,575 @ $0 · Other (J): 8,382 @ $0EDGAR
2022-08-174Tarsus Pharmaceuticals, Inc. (TARS)Other (J): 215,575 @ $0 · Other (J): 3,749 @ $0EDGAR
2022-08-114RxSight, Inc. (RXST)Other (J): 316,694 @ $0 · Other (J): 107,236 @ $0EDGAR
2022-07-014Tarsus Pharmaceuticals, Inc. (TARS)Grant/award (A): 7,000 (derivative) @ $0 · Grant/award (A): 2,000 (derivative) @ $0EDGAR
2022-06-094RxSight, Inc. (RXST)Other (J): 375,000 @ $0 · Other (J): 126,979 @ $0EDGAR
2022-06-084/ARxSight, Inc. (RXST)Other (J): 126,979 @ $0EDGAR
2022-06-084/ARxSight, Inc. (RXST)Other (J): 126,979 @ $0EDGAR
2022-06-034RxSight, Inc. (RXST)Grant/award (A): 10,349 @ $0EDGAR
2022-05-314LENSAR, Inc. (LNSR)Grant/award (A): 4,285 @ $0 · Grant/award (A): 15,616 (derivative) @ $0EDGAR
2022-05-194RxSight, Inc. (RXST)Other (J): 375,000 @ $0EDGAR
2022-03-174RxSight, Inc. (RXST)Other (J): 375,000 @ $0EDGAR
2022-01-074Oyster Point Pharma, Inc. (OYST)Other (J): 6,438 @ $0 · Other (J): 401 @ $0EDGAR
2021-12-234Oyster Point Pharma, Inc. (OYST)Other (J): 6,438 @ $0 · Other (J): 400 @ $0EDGAR
2021-11-164Tarsus Pharmaceuticals, Inc. (TARS)Other (J): 250,000 @ $0 · Other (J): 4,348 @ $0EDGAR
2021-10-204Oyster Point Pharma, Inc. (OYST)Sale (S): 303,614 @ $14.63 · Sale (S): 242,943 @ $15.09 · Sale (S): 1,912 @ $14.63 · Sale (S): 1,531 @ $15.09EDGAR
2021-08-054RxSight, Inc. (RXST)Conversion (C): 2,016,778 @ $0 · Purchase (P): 31,250 @ $16 · Conversion (C): 2,016,778 (derivative) @ $0EDGAR
2021-08-024RxSight, Inc. (RXST)Grant/award (A): 5,859 @ $0EDGAR
2021-06-174Tarsus Pharmaceuticals, Inc. (TARS)Grant/award (A): 10,000 (derivative) @ $0 · Grant/award (A): 10,000 (derivative) @ $0EDGAR
2021-06-094Oyster Point Pharma, Inc. (OYST)Grant/award (A): 3,466 @ $0 · Grant/award (A): 5,199 (derivative) @ $0EDGAR
2021-06-074GLAUKOS Corp (GKOS)Grant/award (A): 2,382 @ $0EDGAR
2021-05-204LENSAR, Inc. (LNSR)Grant/award (A): 20,847 (derivative) @ $0EDGAR
2021-05-144Oyster Point Pharma, Inc. (OYST)Other (J): 10,302 @ $0 · Other (J): 642 @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1228684 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs